Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 8
Submit an article Journal homepage
498
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension

David A. Calhoun University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]
,
Robert D. Glazer Novartis Pharmaceuticals CorporationEast Hanover, NJ, USA
,
Frank S. Pettyjohn University of South Alabama, Mobile, AL, USA
,
P. D. M. Coenen Huisartsenpraktijk Beek en Donk, The Netherlands
,
Yanxing Zhao Novartis Pharmaceuticals CorporationEast Hanover, NJ, USA
&
Amie Grosso Novartis Pharmaceuticals CorporationEast Hanover, NJ, USA
Pages 2303-2311 | Accepted 13 Jun 2008, Published online: 30 Jun 2008

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Chia-Wei Liou, Tung-Chen Yeh, I-Chung Chen, Chi-Hung Huang, Yi-Jen Hung, Kwan-Lih Hsu, Jian-Der Lee, Meng-Huan Lei, Kuan-Cheng Chang, Pei-Yung Liao, Zhih-Cherng Chen, Jackson Wang & Charles Jia-Yin Hou. (2011) Efficacy and safety of valsartan in hypertensive Taiwanese patients: Post-marketing surveillance study. Blood Pressure 20:sup2, pages 13-21.
Read now
David T Nash & Michael S McNamara. (2009) Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility. Integrated Blood Pressure Control 2, pages 39-54.
Read now
Yves Lacourcière, Luc Poirier & Rita Samuel. (2009) Valsartan plus hydrochlorothiazide for first-line therapy in hypertension. Expert Review of Cardiovascular Therapy 7:12, pages 1491-1501.
Read now

Articles from other publishers (9)

Hazel Mae A. Abraham, C. Michael White & William B. White. (2014) The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases. Drug Safety 38:1, pages 33-54.
Crossref
Uday Jadhav, Jagdish Hiremath, Deepak J. Namjoshi, Vinod K. Gujral, Kamlakar K. Tripathi, Mohammad Siraj, Paramesh Shamanna & Michel Safar. (2014) Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study. PLoS ONE 9:4, pages e92955.
Crossref
Mohsen A. Hedaya & Sally A. Helmy. (2013) Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, 4-Period Crossover Study in Healthy Egyptian Male Volunteers. Clinical Therapeutics 35:6, pages 846-861.
Crossref
Howard S Weintraub & Amy Rudolph. (2011) Combination Therapy for Managing Difficult-to-Treat Patients With Stage 2 Hypertension: Focus on Valsartan-Based Combinations. American Journal of Therapeutics 18:6, pages e227-e243.
Crossref
D. Richter, C. Mickel, S. Acharya, P. Brunel & C. Militaru. (2011) Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control. International Journal of Clinical Practice 65:5, pages 613-623.
Crossref
Wen-Ter Lai, Jeong-Euy Park, Neelesh Dongre & Jackson Wang. (2011) Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension. Advances in Therapy 28:5, pages 427-438.
Crossref
M H Weinberger, R D Glazer, N A Crikelair & Y T Chiang. (2010) Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy. Journal of Human Hypertension 24:12, pages 823-830.
Crossref
D H Zappe, B F Palmer, D A Calhoun, D Purkayastha, R Samuel & K A Jamerson. (2009) Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension. Journal of Human Hypertension 24:7, pages 483-491.
Crossref
Henry R. Black, Jacqueline Bailey, Dion Zappe & Rita Samuel. (2009) Valsartan. Drugs 69:17, pages 2393-2414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.